Regeneron Pharmaceuticals Takes Over #112 Spot From Target
August 26, 2016 at 16:38 PM EDT
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Regeneron Pharmaceuticals, Inc. (REGN) has taken over the #112 spot from Target Corp (TGT), according to The Online Investor..